Wang Yanqiang | Atherosclerosis | Best Researcher Award

Posted on 17/03/202517/03/2025 by Pencis

Prof. Wang Yanqiang | Atherosclerosis | Best Researcher Award

Prof. Wang Yanqiang, Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China

Prof. Wang Yanqiang is a distinguished neurologist currently serving in the Department of Neurology II at the Affiliated Hospital of Shandong Second Medical University, China. With a strong academic background, Prof. Wang earned his Master’s degree in Neurology from Xu Zhou Medical University and a Ph.D. from Sun Yat-sen University. His research primarily focuses on the pathogenesis and neuroprotection of ischemic brain injury, Parkinson’s disease, and other cerebrovascular disorders. Over the years, Prof. Wang has held various key positions, including roles as a resident and attending doctor at leading medical institutions in China.

AUTHOR PROFILE

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Wang Yanqiang began his academic journey in the field of neurology, focusing on understanding the intricacies of neurological disorders and brain function. He pursued his medical education and specialized in neurology, laying the foundation for his future contributions in this domain. His early academic training focused on acquiring deep knowledge of neurophysiology, clinical neurology, and neuroanatomy, which would later guide his professional endeavors.

🏥PROFESSIONAL ENDEAVORS:

Prof. Wang Yanqiang holds a distinguished position at the Department of Neurology II at The Affiliated Hospital of Shandong Second Medical University, China. Over the years, he has been a leading figure in both clinical practice and medical research. He has worked tirelessly in patient care, offering specialized neurological treatments and providing critical insights into various neurological conditions. His professional endeavors also include educating and mentoring students, fostering the next generation of neurologists, and playing a key role in advancing clinical practices within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Atherosclerosis

Prof. Wang Yanqiang’s research primarily revolves around neurological disorders, with a particular focus on neurodegenerative diseases, cerebrovascular disorders, and epilepsy. His contributions to the understanding of these diseases have led to significant advancements in both diagnostic techniques and treatment methodologies. His research also spans neuroplasticity, neuroinflammation, and neuroprotective strategies, aiming to develop better therapeutic approaches for patients suffering from neurological impairments. Additionally, Prof. Wang has contributed to the development of diagnostic tools that have improved clinical outcomes in neurology.

🌍IMPACT AND INFLUENCE:

Prof. Wang Yanqiang’s work has had a profound impact on the field of neurology in both China and internationally. His contributions to the understanding of complex neurological diseases have shaped modern clinical practices and research initiatives. His publications and research findings have influenced treatment protocols and inspired further studies in neurodegenerative and cerebrovascular diseases. As a prominent figure in neurology, Prof. Wang has served as a role model for younger neurologists, encouraging a new wave of innovative thinking and patient-centered care in neurology.

📚ACADEMIC CITATIONS AND RECOGNITION:

Prof. Wang Yanqiang’s research has been widely recognized and cited within the academic community. His articles and studies are frequently cited in major neurological journals, reflecting the significance of his work in advancing scientific knowledge in neurology. His contributions have earned him a reputation as a leading expert in the field, with many of his works becoming foundational references for ongoing research. His academic influence is evidenced not only by citations but also through his collaborations with prominent neurologists worldwide.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Wang Yanqiang’s legacy in the field of neurology is marked by his groundbreaking research, dedication to patient care, and commitment to advancing the field. His work has contributed to a better understanding of neurological diseases and has paved the way for innovative treatments. As the field of neurology continues to evolve, Prof. Wang’s influence will likely continue to shape future developments in both clinical practice and medical research. His legacy also includes the mentorship of future generations of neurologists, ensuring that his impact on the field will extend far beyond his career.

🚀CONCLUSION:

Prof. Wang Yanqiang is an esteemed neurologist whose research has greatly advanced our understanding of ischemic brain injury, Parkinson’s disease, and cerebrovascular disorders. With a rich academic background and extensive clinical experience, his contributions to neuroprotection and molecular mechanisms are highly impactful. Through his numerous publications, Prof. Wang has gained international recognition for his work, which continues to influence the field of neurology. His dedication to improving patient outcomes and advancing neurological research makes him a true leader in the medical community.

TOP NOTABLE PUBLICATIONS

Title: Inhibition of the cGAS–STING pathway: contributing to the treatment of cerebral ischemia-reperfusion injury
- Journal: Neural Regeneration Research
- Volume: 2025-07
- Year: 2025
Title: Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review
- Journal: International Journal of Medical Sciences
- Volume: 2024
- Year: 2024
Title: Risk Factors and Clinical Characteristics of First-ever Ischemic Stroke Caused by ICAS with Leukoaraiosis
- Journal: International Journal of Medical Sciences
- Volume: 2024
- Year: 2024
Title: 1,25-D3 ameliorates ischemic brain injury by alleviating endoplasmic reticulum stress and ferroptosis: Involvement of vitamin D receptor and p53 signaling
- Journal: Cellular Signalling
- Volume: 2024-10
- Year: 2024
Title: A case of acute basilar artery occlusion due to atherosclerotic disease revascularized by drug-coated balloon dilation
- Journal: International Journal of Neuroscience
- Volume: 2024-09
- Year: 2024
Title: A case report of drug-coated balloon dilation angioplasty in a patient with acute atherosclerotic basilar artery occlusion
- Journal: Asian Journal of Surgery
- Volume: 2024-09
- Year: 2024
Title: Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021
- Journal: European Journal of Neurology
- Volume: 2024-09-17
- Year: 2024
Title: Genetic insights into the relationship between immune cell characteristics and ischemic stroke: A bidirectional Mendelian randomization study
- Journal: European Journal of Neurology
- Volume: 2024-05
- Year: 2024
Title: Assessing tobacco-related ischemic stroke in Pakistan (1990-2019): Insights from the Global Burden of Disease Study
- Journal: Tobacco Induced Diseases
- Volume: 2024-03-28
- Year: 2024
Title: First report of a p.Cys484Tyr Notch3 mutation in a CADASIL patient with acute bilateral multiple subcortical infarcts—case report and brief review
- Journal: BMC Neurology
- Year: 2024

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Dr. Lingyan Chen, Wenzhou Medical university, China

Dr. Lingyan Chen is an Associate Researcher at Wenzhou Medical University, China, specializing in mitochondrial quality control and disease pathogenesis. She holds a Ph.D. from Wenzhou Medical University (2019-2022) and completed a postdoctoral fellowship at Guangzhou Medical University (2019-2024). Her research focuses on gene knockout models, tumor studies, and cardiovascular pharmacology. She has received multiple awards, including honors from the Circulation Journal Awards (Japan) and the Zhejiang Society of Biochemistry. With extensive experience in molecular biology techniques, Dr. Chen continues to advance biomedical research, aiming to develop novel therapeutic strategies for metabolic and cardiovascular diseases.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Lingyan Chen embarked on her academic journey at Changsha Medical University, earning a B.Sc. degree (2006-2009). She then pursued a M.Sc. at The University of South China (USC) (2015-2018), where she focused on pathogenesis and prevention of atherosclerosis, supported by prestigious research grants. She completed her Ph.D. at Wenzhou Medical University (WMU) (2019-2022), concentrating on mitochondrial quality control and its implications for related diseases.

🏥PROFESSIONAL ENDEAVORS:

🔹 Guangzhou Medical University (Postdoctoral Researcher) (2019-2024) – Advanced research in mitochondrial pathogenesis and disease modeling.
🔹 Guangzhou Medical School (Assistant Professor) (2018) – Engaged in pharmacology research on cardiovascular diseases.
🔹 Guangzhou Medical University (Research Assistant) (2018) – Coordinated multi-institutional research projects and managed key laboratory operations.
🔹 The Second People’s Hospital of Changde (Pediatric Nurse) (2009-2015) – Provided clinical care for newborns and critically ill children, mentoring trainee nurses.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

Dr. Chen’s research spans multiple domains in biomedical sciences, including:
✅ Mitochondrial Quality Control & Disease Mechanisms – Investigated gene knockout/knockin mice models, heterogeneous tumors, and disease modeling for liver cancer and diabetes.
✅ Cardiovascular Pharmacology – Conducted Western Blotting, qPCR, immunofluorescence, and genetic experiments on macrophage behavior.
✅ Atherosclerosis & Hypertriglyceridemia – Studied clinical patient data, serum sample analysis, and statistical evaluations to uncover disease mechanisms.

🌍IMPACT AND INFLUENCE:

Dr. Chen has significantly influenced mitochondrial pathogenesis and cardiovascular research, contributing valuable insights into gene expression, disease prevention, and targeted treatments. Her research findings have aided in therapeutic advancements, particularly in cardiovascular disorders and metabolic diseases.

📚ACADEMIC CITES & LEGACY:

Dr. Chen’s research has been published in top-tier scientific journals, earning citations in the fields of biochemistry, molecular biology, and cardiovascular medicine. Her work serves as a foundation for future studies in mitochondrial dysfunction and therapeutic innovations.

🚀FUTURE CONTRIBUTIONS & VISION:

As an Associate Researcher at Wenzhou Medical University (2025-Present), Dr. Chen continues her groundbreaking research in mitochondrial medicine and disease pathogenesis. She aims to:
🔹 Develop novel therapeutic strategies for cardiovascular and metabolic disorders.
🔹 Expand research on genetic and molecular mechanisms underlying disease progression.
🔹 Mentor the next generation of biomedical researchers and medical professionals.

🏆AWARDS AND HONORS:

🔹 2020 – Second Prize in the 16th Graduate Academic Competition, Wenzhou Medical University
🔹 2020 – Second Prize in the “Xinzhi” Youth Forum, Zhejiang Society of Biochemistry and Molecular Biology
🔹 2018 – Second Prize for Excellent Experimental Research Paper, Circulation Journal Awards (Japan)
🔹 2018 – Outstanding Communist of the University of South China
🔹 2017 – 3rd Prize, Young Investigator Oral Presentation, 14th National Conference on Atherosclerotic Diseases & China-Canada Symposium
🔹 2017 – Excellence Award, Young Investigator Oral Presentation, Cross-Strait Cardiovascular Science Symposium
🔹 2017 – 1st Scholarship, University of South China
🔹 2016 – 2nd Scholarship, University of South China
🔹 2015 – 2nd Scholarship, University of South China

🌟CONCLUSION:

Dr. Lingyan Chen’s dedication to biomedical research, particularly in mitochondrial quality control and cardiovascular pharmacology, has significantly contributed to understanding disease mechanisms and potential treatments. Her extensive experience in molecular biology, combined with numerous accolades and publications, underscores her impact in the scientific community. As she continues her research at Wenzhou Medical University, Dr. Chen remains committed to advancing medical science, mentoring future researchers, and developing innovative therapeutic strategies. Her work holds great promise for improving treatments for metabolic and cardiovascular diseases, making her a valuable figure in the field of biomedical research.

TOP NOTABLE PUBLICATIONS

Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis

Authors: Chen, Lingyan; Chen, Dejian; Pan, Yiming; Zhang, Dawei; Xia, Xiaodan

Journal: Cell Death and Disease

Year: 2024

Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells

Authors: Chen, Lingyan; Chen, Dejian; Li, Jiwei; Lu, Xiaoang; Lu, Bin

Journal: Cell Death and Disease

Year: 2022

MicroRNA-377 inhibits atherosclerosis by regulating triglyceride metabolism through the DNA methyltransferase 1 in apolipoprotein E-knockout mice

Authors: Chen, Lingyan (First Author); Xia, Xiaodan; Zhao, Zhiwei; Gong, Dan; Ma, Xuefeng; Yu, Xuhui; Zhang, Qi; Wang, Shengqi; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Yin, Wende; Tang, ChaoKun

Journal: Circulation Journal

Year: 2018

Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells

Authors: Xia, Xiaodan; Yu, Xuhui; Chen, Lingyan (Co-first Author); Xie, Shuo; Feng, Yan; Yang, Rui; Zhao, Zhiwei; Li, Hui; Wang, Gang; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids

Year: 2021

Heart shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway

Authors: Zhao, Zhiwei; Zhang, Min; Chen, Lingyan (Co-first Author); Gong, Dan; Xia, Xiaodan; Yu, Xuhui; Wang, Shengqi; Ou, Xue; Dai, Xinyu; Zheng, Xianliang; Zhang, Dawei; Tang, ChaoKun

Journal: Biochimica et Biophysica Acta

Year: 2018

Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages

Authors: Li, ChaoHui; Gong, Dan; Chen, Lingyan (Co-first Author); Zhang, Min; Xia, Xiaodan; Cheng, Hongping; Huang, Chen; Zhao, Zhiwei; Zheng, Xianliang; Tang, XueEr; Tang, ChaoKun

Journal: European Journal of Pharmacology

Year: 2017

IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells

Authors: Tang, XueEr; Li, Hui; Chen, Lingyan (Co-first Author); Xia, Xiaodan; Zhao, Zhiwei; Zheng, Xianliang; Zhao, GuoJun; Tang, ChaoKun

Journal: Cytokine

Year: 2019

Wang Yanqiang | Atherosclerosis | Best Researcher Award

Prof. Wang Yanqiang | Atherosclerosis | Best Researcher Award

Prof. Wang Yanqiang, Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China

AUTHOR PROFILE

🎓EARLY ACADEMIC PURSUITS:

🏥PROFESSIONAL ENDEAVORS:

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Atherosclerosis

🌍IMPACT AND INFLUENCE:

📚ACADEMIC CITATIONS AND RECOGNITION:

🌟LEGACY AND FUTURE CONTRIBUTIONS:

🚀CONCLUSION:

TOP NOTABLE PUBLICATIONS

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Dr. Lingyan Chen, Wenzhou Medical university, China

AUTHOR PROFILE

🎓EARLY ACADEMIC PURSUITS:

🏥PROFESSIONAL ENDEAVORS:

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASES:

🌍IMPACT AND INFLUENCE:

📚ACADEMIC CITES & LEGACY:

🚀FUTURE CONTRIBUTIONS & VISION:

🏆AWARDS AND HONORS:

🌟CONCLUSION:

TOP NOTABLE PUBLICATIONS

RECOMMENDED

Mail us